Cohort Studyhigh evidence
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.
The Lancet. Neurology·September 1, 2026·PMID 42586099
Why it mattersPoor fetal growth is a major determinant of perinatal morbidity and long-term health, yet it has been understudied in antiseizure medication exposure. These data provide comparative risk estimates across individual drugs and combinations, informing preconception counseling and treatment selection for women with epilepsy.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled